Navigation Links
Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients

A recent three-way crossover study over six weeks by clinicians at the National Heart and Lung Institute, Royal Brompton Hospital, London has shown that Salmeterol produced a novel anti-neutrophilic effect among patients with mild asthma. The study was prompted by the long standing argument about the effects of long-acting beta2-adrenergic receptor agonists, such as salmeterol, on inflammation. The clinicians enrolled 20 patients, between the ages// of 18 and 55, with mild stable asthma who were randomized to receive salmeterol (50 micrograms b.d), fluticasone propionate (250 micrograms b.d), or placebo. They investigated the effect of salmeterol on the numbers of inflammatory cells in biopsy samples of distinct immuno-phenotype and those expressing the genes for interleukin-4 and -5, regulatory cytokines which are particularly relevant to asthma.

The numbers of neutrophils in bronchial biopsy samples and the concentrations of myeloperoxidase and soluble E-selectin in serum, each of which reflect neutrophil involvement, was found to be significantly reduced in subjects who were given salmeterol compared to those who were given the placebo. Salmeterol, compared with fluticasone propionate, reduced neutrophil number and human neutrophil lipocalin level in bronchial lavage fluid, and intercellular adhesion molecule-1 level in bronchoalveolar lavage fluid. It was also observed that the numbers of (CD3+) T-lymphocytes, (CD4+) T-helper cells, (CD45RO+) activated T-helper cells and eosinophils in the biopsy samples were significantly reduced with fluticasone propionate, compared with placebo. Fluticasone propionate also reduced the percentage of eosinophils and soluble intercellular adhesion molecule-1 in serum.

The clinicians also found that after the use of salmeterol, as compared with both fluticasone propionate and placebo, the airways hyper-responsiveness and the percentage of symptom-free days and nights improved significantly.


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Therapy for Chronic Problem
8. Blood Sugar Kept In Control By Novel Protein
9. Novel antibiotic dressing developed for improved wound healing
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Novel drug holds promise for treatment of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2019)... (PRWEB) , ... May 23, 2019 , ... Spicy Lingerie, ... offering customers a special Memorial Day Weekend at SpicyLingerie.com . With discounts up ... sale is one of the best on offer throughout the weekend. , Eighty ...
(Date:5/23/2019)... (PRWEB) , ... May 23, 2019 , ... Hoban Law ... first nationwide Hemp Is Legal Campaign. “It is essential to help educate the public ... States, surrounding hemp. What better place to do so than Times Square,” said Hoban ...
(Date:5/23/2019)... ... ... Join Dr. Ashok Srivastava, CEO & CMO at ClinFomatrix and CEO at Cure ... Systems, Inc. , in a live webinar on Tuesday, June 11, 2019 ... patient profiles. Together, the two speakers bring years of experience in drug development, medical ...
(Date:5/23/2019)... ... May 23, 2019 , ... Neurohacker Collective ... partnered with Emerson Ecologics. Qualia Mind, Qualia Focus, and Qualia Mind Caffeine Free ... With Emerson’s extensive nearly 40 year history of providing the broadest selection of ...
(Date:5/22/2019)... (PRWEB) , ... May 22, 2019 , ... ... by 55% between Q1 of 2018 and Q1 of 2019 due to the ... Recovery Solutions (HRS). In addition to this steep reduction in readmissions, Community VNA ...
Breaking Medicine News(10 mins):
(Date:5/23/2019)... Fla. (PRWEB) , ... May 23, 2019 , ... More ... 15 for a tearful reunion with medical staff, first responders and community partners. The ... a venue for former patients and families to share their support and stories, continue ...
(Date:5/23/2019)... ... May 23, 2019 , ... Medcom announced today the launch of ... After releasing a new logo and name extension last summer, the next step in ... to be extremely user-friendly with key elements found across the website in numerous locations. ...
(Date:5/23/2019)... Israel (PRWEB) , ... May 23, 2019 , ... ... the treatment of pulmonary arterial hypertension (PAH), today announced the presentation of positive ... System in patients with pulmonary arterial hypertension (PAH) who are on a stable ...
Breaking Medicine Technology: